Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Pharmaceuricals

CTech 24/7

    More stories in CTech

    Pharmaceuricals

    3 stories about Pharmaceuricals
    • מפעל טבע בקנדה

      Closure of another criminal case will help Teva's new CEO to focus on return to growth

      22.08.23|Sophie ShulmanThe pharmaceutical company has reached a compromise after being suspected of price-fixing with other generic drug manufacturers in the US. In the first four years, it will pay $22.5 million and in 2028 - $135 million. In addition, the company will donate two drugs worth $50 million to humanitarian organizations

    • ריצ'רד פרנסיס מנכ"ל טבע החדש על רקע  אתר חברת טבע בכפר סבא

      Schultz kept Teva away from the abyss, but couldn't find a runway to growth

      22.11.22|Sophie ShulmanKare Schultz, who served as CEO of the pharmaceutical company for the past five years, has left the company a year early after amassing a salary of more than $100 million. His replacement, Richard Francis, is taking over with less debt and less legal issues, but with the big challenge of creating new growth engines

    • Drugs (illustartion)

      United Therapeutics to Acquire Pharma Company SteadyMed in a $216 Deal

      30.04.18|Amarelle WenkertIn 2017, Israeli-founded SteadyMed won a patent war against United Therapeutics

    Load more
    Ctech Logo
    Twitter
    Twitter
    Facebook
    Facebook
    NewsLetter
    Newsletter
    Contact Us
    Contact Us
    Rss
    Rss
    About CTech Terms of Use Privacy Policy
    Developed by YIT UI & UX by Basch_Interactive